TRICORDER

Benefits

Early diagnosis of heart failure which currently affects over 2% of the population and consumes 4% of the NHS budget. Currently, 80% of diagnoses are made during emergency admissions, costing the UK over £2 billion annually. The tool is expected to save £2,400 per patient by potentially eliminating emergency room visits, with projected NHS savings of £100 million through nationwide implementation. Benefits include maximized treatment benefits, improved symptoms, quality of life, and survival rates.

View source URL for details

Details

• Tool name: TRICORDER
• Organisation: NHS England Digital Imperial College London Discover NOW London Secure Data Environment Betsi Cadwaladr Health Board National Institute for Health and Care Research
• Status: pilot
• AI method (as recorded): supervised, Machine Learning, Other
• AI method (normalised tags): supervised Machine Learning Other
• Usecase: Health AI
• Origin: digital.nhs.uk
• Owning team: National Heart and Lung Institute, Imperial College London
• Date added: 6 August 2024
• Source note: The TRICORDER project uses an AI-powered tool called Eko-DUO to identify patients at risk of heart failure through GP records, revolutionizing heart failure diagnosis and treatment in primary care. It involves over 200 GP practices and has received £1.18 million in funding from the NIHR. [Source]
• Source URL: https://digital.nhs.uk/data-and-information/research-powered-by-data/life-saving-research/case-studies/tricorder